Wang WC, Oyeku SO, Luo Z, Boulet SL, Miller ST, Fish B, Thompson BW, Grosse SD.
[Read Summary][Read Key Findings]
A panel of federal and community stakeholders met at the American Society of Hematology (ASH) headquarters in Washington, DC on August 22, 2012. The primary objectives for this meeting included: 1) identify priorities and the corresponding activities that should be addressed in sickle cell disease (SCD) and 2) determine which activities would be most appropriately accomplished by the Centers for Disease Control and Prevention (CDC) in partnership with other stakeholders. The notes from this meeting were summarized and will direct programmatic efforts at CDC toward improving the lives of individuals living with Sickle Cell Disease.
[Read Summary ]
Pediatric Blood Cancer, October 2009; 53(4) 642-6.
Mvundura M, Amendah D, Kavanagh PL, Sprinz PG, Grosse SD
The Journal of Pediatrics; April 2009; 154(4), 541-5
Yanni E, Grosse S, Yang Q, Olney RS
The objective was to analyze trends in sickle cell disease (SCD)-related mortality among black children during 1983-2002. The conclusion was that recent decreases in SCD mortality in black children under age 4 years coincided with the introduction of the 7-valent pneumococcal conjugate vaccine in 2000, although temporal association is not evidence of causation.
Pediatrics; October 2007; 120(4):e749-e755
Lobato MN, et al
Contraception; February 2006; 73(2):195-204
Legardy J, et al
Additional Selected Articles
American Journal of Clinical Nutrition; 2004; 79:466-72
Terlouw D, et al
The Journal of Infectious Diseases; 2002; 186:1661-8
Terlouw D, et al
The Lancet; 2002; 359:1311-1312
Aidoo M, et al
Morbidity and Mortality Weekly Report; August 18, 2000; 49(32); 729-731
Genomics and Public Health in the 21st Century; July 2000
American Journal of Epidemiology; 2000 May 1; 151(9): 839-845
Ashley-Koch A, Yang Q, Olney RS
American Journal of Preventive Medicine; 1999; 16(2):116-121
Morbidity and Mortality Weekly Report; 1998; 47:169-172
Simon Dyson BSc; MPhil; PhD
Unit for the Social Study of Thalassaemia and Sickle Cell,
De Montfort University, Leicester, United Kingdom